Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.

Alexandru Schiopu; Jenny Bengtsson; Ingrid Söderberg; Sabina Janciauskiene; Stefan Lindgren; Mikko P S Ares; Prediman K Shah; Roland Carlsson; Jan Nilsson; Gunilla Nordin Fredrikson

doi:10.1161/01.CIR.0000143162.56057.B5

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.

Identifier:nobleid.org/w1/20260515/9CC33765

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9CC33765.svg?ark=w1%2F20260515%2F9CC33765)](https://nobleid.org/work/w1/20260515/9CC33765)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Gunilla Nordin Fredrikson

Claim authorship of this work

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.

Identifier:nobleid.org/w1/20260515/9CC33765

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9CC33765.svg?ark=w1%2F20260515%2F9CC33765)](https://nobleid.org/work/w1/20260515/9CC33765)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Gunilla Nordin Fredrikson

Claim authorship of this work